Clinical Trial Update: Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)

View source ↗

Summary

Completed clinical trial evaluating the effect of certolizumab pegol on lower extremity lymph flow in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: University of Rochester | Conditions: Rheumatoid Arthritis | Status: COMPLETED